Back to School: How biopharma can reboot drug development. Access exclusive analysis here

G3139: Began Phase III trial

Genta Inc. (GNTA), Lexington, Mass.
Product: G3139
Business:

Read the full 81 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE